Thus, our results suggest that, like in neurofibromatosis type 1, pagetic patient carriers of a SQSTM1/P392L post-zygotic mutation would develop a less extensive bone involvement than patients harboring the germ line mutation. Here, SQSTM1 is linked to neurofibromatosis type 1.